Correlation Between Affimed NV and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Affimed NV and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Affimed NV and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Affimed NV and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Affimed NV and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Affimed NV with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Affimed NV and Reviva Pharmaceuticals.
Diversification Opportunities for Affimed NV and Reviva Pharmaceuticals
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Affimed and Reviva is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Affimed NV and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Affimed NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Affimed NV are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Affimed NV i.e., Affimed NV and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Affimed NV and Reviva Pharmaceuticals
Given the investment horizon of 90 days Affimed NV is expected to generate 0.64 times more return on investment than Reviva Pharmaceuticals. However, Affimed NV is 1.56 times less risky than Reviva Pharmaceuticals. It trades about -0.16 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about -0.12 per unit of risk. If you would invest 127.00 in Affimed NV on December 26, 2024 and sell it today you would lose (40.00) from holding Affimed NV or give up 31.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Affimed NV vs. Reviva Pharmaceuticals Holding
Performance |
Timeline |
Affimed NV |
Reviva Pharmaceuticals |
Affimed NV and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Affimed NV and Reviva Pharmaceuticals
The main advantage of trading using opposite Affimed NV and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Affimed NV position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.Affimed NV vs. ADC Therapeutics SA | Affimed NV vs. Agenus Inc | Affimed NV vs. X4 Pharmaceuticals | Affimed NV vs. Terns Pharmaceuticals |
Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Money Managers Screen money managers from public funds and ETFs managed around the world |